Market Analysis and Insights: Global Multiplex Molecular Diagnosis Technology Market
The global Multiplex Molecular Diagnosis Technology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Multiplex Molecular Diagnosis Technology market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Multiplex Molecular Diagnosis Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiplex Molecular Diagnosis Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multiplex Molecular Diagnosis Technology revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Multiplex Molecular Diagnosis Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Multiplex Molecular Diagnosis Technology revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Siemens
Hologic
Thermo Fisher Scientific
Koninklijke Philips N.V.
NeuroLogica
Shimadzu Medical
GENERAL ELECTRIC
Sysmex
Canon
FUJIFILM Holdings
Bio-Rad Laboratories
Roche Diagnostics
Luminex Corporation
Abbott Laboratories
QIAGEN
Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low Density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Segment by Application
Hospital
Outpatient Surgery Centre
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Multiplex Molecular Diagnosis Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Molecular Diagnosis Technology companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiplex Molecular Diagnosis Technology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Real-time PCR
1.2.3 Nested PCR with Melt Curve Analysis
1.2.4 PCR with Low Density Microarray
1.2.5 PCR with Liquid Phase Bead Array
1.2.6 PCR with Electrochemical Detection
1.3 Market by Application
1.3.1 Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Outpatient Surgery Centre
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Molecular Diagnosis Technology Market Perspective (2019-2030)
2.2 Global Multiplex Molecular Diagnosis Technology Growth Trends by Region
2.2.1 Multiplex Molecular Diagnosis Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multiplex Molecular Diagnosis Technology Historic Market Size by Region (2019-2024)
2.2.3 Multiplex Molecular Diagnosis Technology Forecasted Market Size by Region (2025-2030)
2.3 Multiplex Molecular Diagnosis Technology Market Dynamics
2.3.1 Multiplex Molecular Diagnosis Technology Industry Trends
2.3.2 Multiplex Molecular Diagnosis Technology Market Drivers
2.3.3 Multiplex Molecular Diagnosis Technology Market Challenges
2.3.4 Multiplex Molecular Diagnosis Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Multiplex Molecular Diagnosis Technology by Players
3.1.1 Global Multiplex Molecular Diagnosis Technology Revenue by Players (2019-2024)
3.1.2 Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Players (2019-2024)
3.2 Global Multiplex Molecular Diagnosis Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multiplex Molecular Diagnosis Technology, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Multiplex Molecular Diagnosis Technology Market Concentration Ratio
3.4.1 Global Multiplex Molecular Diagnosis Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Molecular Diagnosis Technology Revenue in 2023
3.5 Global Key Players of Multiplex Molecular Diagnosis Technology Head office and Area Served
3.6 Global Key Players of Multiplex Molecular Diagnosis Technology, Product and Application
3.7 Global Key Players of Multiplex Molecular Diagnosis Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Molecular Diagnosis Technology Breakdown Data by Type
4.1 Global Multiplex Molecular Diagnosis Technology Historic Market Size by Type (2019-2024)
4.2 Global Multiplex Molecular Diagnosis Technology Forecasted Market Size by Type (2025-2030)
5 Multiplex Molecular Diagnosis Technology Breakdown Data by Application
5.1 Global Multiplex Molecular Diagnosis Technology Historic Market Size by Application (2019-2024)
5.2 Global Multiplex Molecular Diagnosis Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multiplex Molecular Diagnosis Technology Market Size (2019-2030)
6.2 North America Multiplex Molecular Diagnosis Technology Market Size by Type
6.2.1 North America Multiplex Molecular Diagnosis Technology Market Size by Type (2019-2024)
6.2.2 North America Multiplex Molecular Diagnosis Technology Market Size by Type (2025-2030)
6.2.3 North America Multiplex Molecular Diagnosis Technology Market Share by Type (2019-2030)
6.3 North America Multiplex Molecular Diagnosis Technology Market Size by Application
6.3.1 North America Multiplex Molecular Diagnosis Technology Market Size by Application (2019-2024)
6.3.2 North America Multiplex Molecular Diagnosis Technology Market Size by Application (2025-2030)
6.3.3 North America Multiplex Molecular Diagnosis Technology Market Share by Application (2019-2030)
6.4 North America Multiplex Molecular Diagnosis Technology Market Size by Country
6.4.1 North America Multiplex Molecular Diagnosis Technology Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Multiplex Molecular Diagnosis Technology Market Size by Country (2019-2024)
6.4.3 North America Multiplex Molecular Diagnosis Technology Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Multiplex Molecular Diagnosis Technology Market Size (2019-2030)
7.2 Europe Multiplex Molecular Diagnosis Technology Market Size by Type
7.2.1 Europe Multiplex Molecular Diagnosis Technology Market Size by Type (2019-2024)
7.2.2 Europe Multiplex Molecular Diagnosis Technology Market Size by Type (2025-2030)
7.2.3 Europe Multiplex Molecular Diagnosis Technology Market Share by Type (2019-2030)
7.3 Europe Multiplex Molecular Diagnosis Technology Market Size by Application
7.3.1 Europe Multiplex Molecular Diagnosis Technology Market Size by Application (2019-2024)
7.3.2 Europe Multiplex Molecular Diagnosis Technology Market Size by Application (2025-2030)
7.3.3 Europe Multiplex Molecular Diagnosis Technology Market Share by Application (2019-2030)
7.4 Europe Multiplex Molecular Diagnosis Technology Market Size by Country
7.4.1 Europe Multiplex Molecular Diagnosis Technology Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Multiplex Molecular Diagnosis Technology Market Size by Country (2019-2024)
7.4.3 Europe Multiplex Molecular Diagnosis Technology Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Multiplex Molecular Diagnosis Technology Market Size (2019-2030)
8.2 China Multiplex Molecular Diagnosis Technology Market Size by Type
8.2.1 China Multiplex Molecular Diagnosis Technology Market Size by Type (2019-2024)
8.2.2 China Multiplex Molecular Diagnosis Technology Market Size by Type (2025-2030)
8.2.3 China Multiplex Molecular Diagnosis Technology Market Share by Type (2019-2030)
8.3 China Multiplex Molecular Diagnosis Technology Market Size by Application
8.3.1 China Multiplex Molecular Diagnosis Technology Market Size by Application (2019-2024)
8.3.2 China Multiplex Molecular Diagnosis Technology Market Size by Application (2025-2030)
8.3.3 China Multiplex Molecular Diagnosis Technology Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Multiplex Molecular Diagnosis Technology Market Size (2019-2030)
9.2 Asia Multiplex Molecular Diagnosis Technology Market Size by Type
9.2.1 Asia Multiplex Molecular Diagnosis Technology Market Size by Type (2019-2024)
9.2.2 Asia Multiplex Molecular Diagnosis Technology Market Size by Type (2025-2030)
9.2.3 Asia Multiplex Molecular Diagnosis Technology Market Share by Type (2019-2030)
9.3 Asia Multiplex Molecular Diagnosis Technology Market Size by Application
9.3.1 Asia Multiplex Molecular Diagnosis Technology Market Size by Application (2019-2024)
9.3.2 Asia Multiplex Molecular Diagnosis Technology Market Size by Application (2025-2030)
9.3.3 Asia Multiplex Molecular Diagnosis Technology Market Share by Application (2019-2030)
9.4 Asia Multiplex Molecular Diagnosis Technology Market Size by Region
9.4.1 Asia Multiplex Molecular Diagnosis Technology Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Multiplex Molecular Diagnosis Technology Market Size by Region (2019-2024)
9.4.3 Asia Multiplex Molecular Diagnosis Technology Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Type
10.2.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Application
10.3.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Country
10.4.1 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Multiplex Molecular Diagnosis Technology Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Multiplex Molecular Diagnosis Technology Introduction
11.1.4 Siemens Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.1.5 Siemens Recent Developments
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Multiplex Molecular Diagnosis Technology Introduction
11.2.4 Hologic Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.2.5 Hologic Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Introduction
11.3.4 Thermo Fisher Scientific Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Koninklijke Philips N.V.
11.4.1 Koninklijke Philips N.V. Company Details
11.4.2 Koninklijke Philips N.V. Business Overview
11.4.3 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Introduction
11.4.4 Koninklijke Philips N.V. Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.4.5 Koninklijke Philips N.V. Recent Developments
11.5 NeuroLogica
11.5.1 NeuroLogica Company Details
11.5.2 NeuroLogica Business Overview
11.5.3 NeuroLogica Multiplex Molecular Diagnosis Technology Introduction
11.5.4 NeuroLogica Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.5.5 NeuroLogica Recent Developments
11.6 Shimadzu Medical
11.6.1 Shimadzu Medical Company Details
11.6.2 Shimadzu Medical Business Overview
11.6.3 Shimadzu Medical Multiplex Molecular Diagnosis Technology Introduction
11.6.4 Shimadzu Medical Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.6.5 Shimadzu Medical Recent Developments
11.7 GENERAL ELECTRIC
11.7.1 GENERAL ELECTRIC Company Details
11.7.2 GENERAL ELECTRIC Business Overview
11.7.3 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Introduction
11.7.4 GENERAL ELECTRIC Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.7.5 GENERAL ELECTRIC Recent Developments
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex Multiplex Molecular Diagnosis Technology Introduction
11.8.4 Sysmex Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.8.5 Sysmex Recent Developments
11.9 Canon
11.9.1 Canon Company Details
11.9.2 Canon Business Overview
11.9.3 Canon Multiplex Molecular Diagnosis Technology Introduction
11.9.4 Canon Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.9.5 Canon Recent Developments
11.10 FUJIFILM Holdings
11.10.1 FUJIFILM Holdings Company Details
11.10.2 FUJIFILM Holdings Business Overview
11.10.3 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Introduction
11.10.4 FUJIFILM Holdings Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.10.5 FUJIFILM Holdings Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Introduction
11.11.4 Bio-Rad Laboratories Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Details
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics Multiplex Molecular Diagnosis Technology Introduction
11.12.4 Roche Diagnostics Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.12.5 Roche Diagnostics Recent Developments
11.13 Luminex Corporation
11.13.1 Luminex Corporation Company Details
11.13.2 Luminex Corporation Business Overview
11.13.3 Luminex Corporation Multiplex Molecular Diagnosis Technology Introduction
11.13.4 Luminex Corporation Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.13.5 Luminex Corporation Recent Developments
11.14 Abbott Laboratories
11.14.1 Abbott Laboratories Company Details
11.14.2 Abbott Laboratories Business Overview
11.14.3 Abbott Laboratories Multiplex Molecular Diagnosis Technology Introduction
11.14.4 Abbott Laboratories Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.14.5 Abbott Laboratories Recent Developments
11.15 QIAGEN
11.15.1 QIAGEN Company Details
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN Multiplex Molecular Diagnosis Technology Introduction
11.15.4 QIAGEN Revenue in Multiplex Molecular Diagnosis Technology Business (2019-2024)
11.15.5 QIAGEN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Siemens
Hologic
Thermo Fisher Scientific
Koninklijke Philips N.V.
NeuroLogica
Shimadzu Medical
GENERAL ELECTRIC
Sysmex
Canon
FUJIFILM Holdings
Bio-Rad Laboratories
Roche Diagnostics
Luminex Corporation
Abbott Laboratories
QIAGEN
听
听
*If Applicable.
